Cargando…

Association of salivary RANKL and osteoprotegerin levels with periodontal health

The aim of this study is to determine the association of salivary levels of the bone remodelling regulators (RANKL) and osteoprotegerin (OPG) with periodontal clinical status. One‐hundred fifty‐eight participants selected from a pool of adult patients via systematic random sampling were included in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochanji, A. A., Matu, N. K., Mulli, T. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719813/ https://www.ncbi.nlm.nih.gov/pubmed/29744178 http://dx.doi.org/10.1002/cre2.49

Ejemplares similares

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitis
por: Behfarnia, Parichehr, et al.
Publicado: (2016)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

RANK, RANKL and osteoprotegerin in bone biology and disease
por: Wright, H. L., et al.
Publicado: (2009)

Assessment of Salivary Levels of RANKL and OPG in Aggressive versus Chronic Periodontitis
por: Teodorescu, Alexandra Cornelia, et al.
Publicado: (2019)

Erratum: Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitis
Publicado: (2016)

NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL
por: Irtyuga, Olga, et al.
Publicado: (2017)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
por: Chi, Guanghao, et al.
Publicado: (2023)

The effect of Phase 1 periodontal treatment on the salivary RANKL/OPG ratio in severe chronic periodontitis
por: Ansari Moghadam, Somaye, et al.
Publicado: (2019)

Investigation of Salivary RANKL and OPG Levels in Periodontitis Patients at Hospital Universiti Sains Malaysia
por: Asif, Saba, et al.
Publicado: (2021)

Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2015)

Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health
por: Tabari, Zahra Alizadeh, et al.
Publicado: (2013)

The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
por: Starlinger, Julia, et al.
Publicado: (2019)

Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study
por: Amer, Osama E., et al.
Publicado: (2022)

Diagnostic potential of salivary interleukin‐17, RANKL, and OPG to differentiate between periodontal health and disease and discriminate stable and unstable periodontitis: A case‐control study
por: Abdullameer, Marwa A., et al.
Publicado: (2023)

Salivary Gene Expression of RANK, RANKL, and OPG in Type 1 Diabetes Mellitus and Periodontal Disease Patients
por: Chairatnathrongporn, Rachanin, et al.
Publicado: (2022)

Role of RANKL–RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications
por: Kohli, Sarvraj Singh, et al.
Publicado: (2011)

Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment
por: Sfiridaki, K., et al.
Publicado: (2011)

RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes
por: Kondegowda, Nagesha Guthalu, et al.
Publicado: (2023)

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
por: Dutka, Mieczysław, et al.
Publicado: (2021)

Effect of Periodontal Surgery on Osteoprotegerin Levels in Gingival Crevicular Fluid, Saliva, and Gingival Tissues of Chronic Periodontitis Patients
por: Hassan, Sandy H. S., et al.
Publicado: (2015)

Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL
por: Schieferdecker, Aneta, et al.
Publicado: (2014)

RANKL Expression in Periodontal Disease: Where Does RANKL Come from?
por: Chen, Bin, et al.
Publicado: (2014)

Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis
por: Kurz, Katharina, et al.
Publicado: (2015)

Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits
por: Lv, You, et al.
Publicado: (2014)

Gingival crevicularfluid osteoprotegerin levels in Indian population
por: Bandari, Purnima, et al.
Publicado: (2012)

Salivary biomarkers in association with periodontal parameters and the periodontitis risk haplotype
por: Liukkonen, Joonas, et al.
Publicado: (2018)

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
por: Picarda, Gaëlle, et al.
Publicado: (2013)

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
por: Widschwendter, Martin, et al.
Publicado: (2015)

Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells
por: Su, Fang, et al.
Publicado: (2015)

Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease
por: Kajiya, Mikihito, et al.
Publicado: (2010)

Effect of nonsurgical periodontal therapy on salivary melatonin levels in patients with periodontal disease
por: Megavath, Sravani, et al.
Publicado: (2023)

Comparative evaluation of salivary soluble CD44 levels in periodontal health and disease
por: Kaur, Sumeet, et al.
Publicado: (2014)

Mesenchymal stem cells inhibit RANK-RANKL interactions between osteoclasts and Th17 cells via osteoprotegerin activity
por: Cho, Kyung-Ah, et al.
Publicado: (2017)

Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system
por: Skarlis, Charalampos, et al.
Publicado: (2018)

Osteoprotegerin in Cardiometabolic Disorders
por: Pérez de Ciriza, C., et al.
Publicado: (2015)

Effect of smoking on salivary composition and periodontal status
por: Kolte, Abhay P., et al.
Publicado: (2012)

Parathyroid Hormone on Osteoprotegerin Levels in Patients with Primary Hyperparathyroidism
por: Okudan, Berna, et al.
Publicado: (2022)

Association among stress, salivary cortisol levels, and chronic periodontitis
por: Refulio, Zoila, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nh4e7l45ogbkbt6oj38sco1tr4